Continued R&D Activities
First written in FY2017-Q1. . Latest entry: FY2026.
90 other companies' latest entry also says "Other".
- FY2026Increase in R&D SpendingAnnual report
「Total R&D expenses for the current consolidated fiscal year were ¥2,104 million.」
Full-year R&D expenses were ¥2,104 million, up from ¥1,673 million in the previous fiscal year. - FY2026-H1Increase in R&D SpendingAnnual report
「The Group's total R&D expenditure for the current interim consolidated accounting period was ¥860 million.」
R&D expenses for the interim period were ¥860 million, up from ¥715 million in the same period of the previous year. The company stated that there were no material changes in its R&D activities. - FY2025Increase in R&D SpendingAnnual report
「Total R&D expenses for the current consolidated fiscal year were ¥1,673 million.」
Full-year R&D expenses were ¥1,673 million, up from ¥1,409 million in the previous fiscal year. - FY2025-H1Increase in R&D SpendingAnnual report
「The Group's total R&D expenditure for the current interim consolidated accounting period was ¥715 million.」
R&D expenses for the interim period were ¥715 million, up from ¥707 million in the same period of the previous year. The company stated that there were no material changes in its R&D activities. - FY2024R&D expenses decreasedAnnual report
「Total R&D expenses for the current consolidated fiscal year were ¥1,409 million.」
Full-year R&D expenses were ¥1,409 million, down from ¥1,429 million in the previous fiscal year. - FY2024-Q3R&D expenses were broadly flatAnnual report
「The Group's total R&D expenditure for the first three quarters of the current consolidated fiscal year was ¥1,062 million.」
R&D expenses for the first three quarters were ¥1,062 million, broadly flat and slightly down from ¥1,063 million in the same period of the previous year. - FY2024-Q2Increase in R&D SpendingAnnual report
「The Group's total R&D expenditure for the first two quarters of the current consolidated fiscal year was ¥707 million.」
R&D expenses for the first two quarters were ¥707 million, up from ¥701 million in the same period of the previous year. - FY2024-Q1Increase in R&D SpendingAnnual report
「The Group's total R&D expenditure for the first quarter of the current consolidated fiscal year was ¥356 million.」
R&D expenses for the first quarter were ¥356 million, up from ¥344 million in the same period of the previous year. - FY2023R&D expenses decreasedAnnual report
「Total research and development expenses for the current consolidated fiscal year were ¥1,429 million.」
Full-year R&D expenses were ¥1,429 million, down from ¥1,447 million in the previous fiscal year. - FY2023-Q3R&D expenses decreasedAnnual report
「The amount spent on research and development activities across the Group during the first nine months of the current consolidated fiscal year was ¥1,063 million.」
Research and development activity expenses for the cumulative third quarter were ¥1,063 million, down from ¥1,127 million in the same period of the previous year. - FY2023-Q2R&D expenses decreasedAnnual report
「The amount spent on research and development activities across our Group during the first half of the current consolidated fiscal year was ¥701 million.」
Research and development activity expenses for the cumulative second quarter were ¥701 million, down from ¥749 million in the same period of the previous year. - FY2023-Q1R&D expenses decreasedAnnual report
「The amount spent on research and development activities across the Group during the first quarter of the current consolidated fiscal year was ¥344 million.」
Research and development activity expenses for the first quarter were ¥344 million, down from ¥361 million in the same period of the previous year. - FY2022Increase in R&D SpendingAnnual report
「Total research and development expenses for the current consolidated fiscal year were ¥1,447 million.」
Full-year research and development expenses were ¥1,447 million, up from ¥1,305 million in the previous fiscal year. - FY2022-Q3Increase in R&D SpendingAnnual report
「The amount spent on research and development activities across the Group during the first nine months of the current consolidated fiscal year was ¥1,127 million.」
Research and development activity expenses for the cumulative third quarter were ¥1,127 million, exceeding ¥819 million in the same period of the previous year and ¥749 million in the cumulative previous quarter. - FY2022-Q2Increase in R&D SpendingAnnual report
「The amount spent on research and development activities across our Group during the first half of the current consolidated fiscal year was ¥749 million.」
Research and development activity expenses for the cumulative second quarter were ¥749 million, exceeding ¥616 million in the same period of the previous year and ¥361 million in the cumulative previous quarter. - FY2022-Q1Increase in R&D SpendingAnnual report
「The amount spent on research and development activities across the Group during the first quarter of the current consolidated fiscal year was ¥361 million.」
Research and development activity expenses for the cumulative first quarter were ¥361 million, up from ¥292 million in the same period of the previous year. - FY2021Increase in R&D SpendingAnnual report
「Total research and development expenses for the current consolidated fiscal year were ¥1,305 million. The company constructed a research and development facility near its head office and invested ¥1,723 million.」
Full-year research and development expenses were ¥1,305 million, and ¥1,723 million was also invested in the construction of a research and development facility. - FY2021-Q3Increase in R&D SpendingAnnual report
「The amount spent on research and development activities across the Group during the first nine months of the current consolidated fiscal year was ¥942 million.」
Research and development activity expenses for the cumulative third quarter were ¥942 million, up from ¥819 million in the same period of the previous year. - FY2021-Q2Increase in R&D SpendingAnnual report
「The amount spent on research and development activities across our Group during the first half of the current consolidated fiscal year was ¥616 million.」
Research and development activity expenses for the cumulative second quarter were ¥616 million, up from ¥549 million in the same period of the previous year. - FY2021-Q1Increase in R&D SpendingAnnual report
「The amount spent on research and development activities across the Group during the first quarter of the current consolidated fiscal year was ¥292 million.」
Research and development activity expenses for the cumulative first quarter were ¥292 million, up from ¥284 million in the same period of the previous year. - FY2020Increase in R&D SpendingAnnual report
「Total research and development expenses for the current consolidated fiscal year were ¥1,105 million.」
Full-year research and development expenses were ¥1,105 million, up from ¥974 million in the previous fiscal year. - FY2020-Q3Increase in R&D SpendingAnnual report
「The amount spent on research and development activities across the Group during the first nine months of the current consolidated fiscal year was ¥819 million.」
Research and development activity expenses for the cumulative third quarter were ¥819 million, exceeding ¥682 million in the same period of the previous year and ¥549 million in the cumulative previous quarter. - FY2020-Q2Increase in R&D SpendingAnnual report
「The amount spent on research and development activities across the Group during the first half of the current consolidated fiscal year was ¥549 million.」
Research and development activity expenses for the cumulative second quarter were ¥549 million, exceeding ¥419 million in the same period of the previous year and ¥284 million in the cumulative first quarter. - FY2020-Q1Increase in R&D SpendingAnnual report
「The amount spent on research and development activities across the Group during the first quarter of the current consolidated fiscal year was ¥284 million.」
Research and development activity expenses for the cumulative first quarter were ¥284 million, up from ¥206 million in the same period of the previous year. - FY2019Increase in R&D SpendingAnnual report
「Total research and development expenses for the current consolidated fiscal year were ¥974 million.」
Full-year research and development expenses were ¥974 million, up from ¥840 million in the previous fiscal year. - FY2019-Q3Increase in R&D SpendingAnnual report
「The amount spent on research and development activities across our Group during the first nine months of the current consolidated fiscal year was ¥682 million.」
Research and development activity expenses for the cumulative third quarter were ¥682 million, exceeding ¥624 million in the same period of the previous year and ¥419 million in the cumulative second quarter of the current fiscal year. - FY2019-Q2Increase in R&D SpendingAnnual report
「The amount spent on research and development activities across the Group during the first half of the current consolidated fiscal year was ¥419 million.」
The amount spent on research and development activities in the cumulative second quarter was ¥419 million, exceeding ¥407 million in the same period of the previous year and ¥206 million in the cumulative previous quarter. - FY2019-Q1Increase in R&D SpendingAnnual report
「The amount spent on research and development activities across the Group during the first quarter of the current consolidated fiscal year was ¥206 million.」
The amount spent on research and development activities in the cumulative first quarter was ¥206 million, exceeding ¥201 million in the same period of the previous year. - FY2018-Q3Increase in R&D SpendingAnnual report
「The amount spent on research and development activities across our Group during the first nine months of the current consolidated fiscal year was ¥624 million.」
The amount spent on research and development activities in the cumulative third quarter was ¥624 million, exceeding ¥597 million in the same period of the previous year and ¥407 million in the cumulative previous quarter. - FY2018-Q2Increase in R&D SpendingAnnual report
「The amount spent on research and development activities across the Group during the first half of the current consolidated fiscal year was ¥407 million.」
The amount spent on research and development activities in the cumulative second quarter was ¥407 million, exceeding ¥371 million in the same period of the previous year and ¥201 million in the cumulative previous quarter. - FY2018-Q1Increase in R&D SpendingAnnual report
「The amount spent on research and development activities across the Group during the first quarter of the current consolidated fiscal year was ¥201 million.」
The amount spent on research and development activities in the cumulative first quarter was ¥201 million, up from ¥171 million in the same period of the previous year. - FY2017Increase in R&D SpendingAnnual report
「Total research and development expenses for the current consolidated fiscal year were ¥805 million.」
Full-year research and development expenses were ¥805 million, up from ¥597 million in the cumulative third quarter. - FY2017-Q3Increase in R&D SpendingAnnual report
「The amount spent on research and development activities across our Group during the first nine months of the current consolidated fiscal year was ¥597 million.」
The amount spent on research and development activities was ¥597 million, up from ¥371 million in the cumulative second quarter. - FY2017-Q2Increase in R&D SpendingAnnual report
「The amount spent on research and development activities across the Group during the first half of the current consolidated fiscal year was ¥371 million.」
The amount spent on research and development activities was reported as ¥371 million, up from ¥171 million in the cumulative first quarter of the previous period. - FY2017-Q1First statedAnnual report
「The amount spent on research and development activities across the Group during the first quarter of the current consolidated fiscal year was ¥171 million.」
Research and development activity expenses for the quarter were reported as ¥171 million.